To diffuse technology or not to diffuse: that’s the question

On the one hand, access is the first ingredient in innovation. On the other, letting technology flow freely could lead to misuse and regulatory trouble.

Sound arguments can be made both for and against the diffusion of modern biotechnologies, writes Prof. Marc Saner.The Hill Times photograph by Sam Garcia

Opinion

BY MARC SANER

September 20, 2017

Let me give you a choice between two compelling narratives on the topic of diffusion—efforts to make technologies available by means of government policies. The first is an argument for the broad diffusion of biotechnologies, including synthetic biology and CRISPR (a genome editing tool). The oth...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy